All News

06/03 UBS Lowers Price Target for Genmab to 2,600 Danish Kroner (from 2,750), Reiterates Buy FW
06/03 Nordic Stocks in North America - Autoliv Drops 0.4 Percent FW
04/03 Genmab A/S : Articles of association dated February 27, 2026 – English PU
04/03 Genmab A/S : has published its Articles of Association PU
04/03 SHB Sees Multiple Potential Share Price Triggers for Genmab, Raises Target Price FW
03/03 Handelsbanken Raises Genmab Price Target to 2,220 Danish Kroner (from 2,200), Reiterates Buy - BN FW
03/03 Correction to Company Announcement No. 13 of March 2, 2026 AQ
03/03 Correction to Company Announcement No. 13 of March 2, 2026 GL
02/03 Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab AQ
02/03 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons AQ
02/03 Transactions in Connection with Share Buy-back Program GL
02/03 Nordic Stocks in North America - Ericsson Up 0.7 Percent FW
28/02 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons GL
28/02 Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab GL
27/02 Nordic Stocks in North America - Ericsson Up 0.5 Percent FW
25/02 Genmab to Participate in Upcoming Investor Conferences GL
25/02 Genmab A/S : Articles of association dated February 24, 2026 – English PU
25/02 Genmab A/S : has published its Articles of Association PU
25/02 Capital Increase in Genmab as a Result of Employee Warrant Exercise GL
23/02 Transactions in Connection with Share Buy-back Program GL
23/02 Bernstein Raises Price Target for Genmab to 1,400 Danish Kroner (from 1,015), Reiterates Underperform - BN FW
20/02 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons GL
19/02 BofA Bullish on Genmab's FY26 Catalyst Path; Buy Rating Maintained MT
18/02 Notice to Convene the Annual General Meeting of Genmab A/S GL
18/02 Genmab: 2025 miss and cautious 2026 targets erode investor confidence Alphavalue
No results for this search
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW